Form 4: BioLife Solutions CMO Sells Shares for Tax Obligations

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 289 shares of common stock for $27.36 per share to cover tax withholding obligations related to restricted stock vesting.

Summary

• Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 289 shares of common stock.
• The shares were sold at a price of $27.36 per share.
• The transaction date was October 9, 2025.
• Following this transaction, Todd Berard beneficially owns 133,617 shares of common stock directly.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations in connection with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary sale by an insider to cover tax obligations associated with restricted stock vesting, executed under a pre-arranged 10b5-1 trading plan. It does not indicate a change in management's outlook or company fundamentals.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction filing, common across all industries, and does not provide specific insights into broader industry trends or competitive landscape for BioLife Solutions.

Stakeholder Impact

• Shareholders: Minimal impact as the sale is a routine, pre-planned transaction for tax purposes and not indicative of a change in company fundamentals or management's confidence.

Key Dates

Recommendation

The sale by the Chief Marketing Officer is a routine transaction to satisfy tax withholding obligations related to restricted stock vesting, executed under a pre-established 10b5-1 trading plan. This type of transaction is not typically indicative of a change in management's outlook or the company's fundamentals, thus a 'hold' recommendation is maintained.

Keywords

BioLife Solutions, BLFS, Insider Transaction, Form 4, Stock Sale, Todd Berard, Chief Marketing Officer, 10b5-1 Plan, Tax Withholding